9.770USD+92.70%Mkt Cap: 34.56M USDP/E: —Last update: 2026-05-26
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap34.56M USD
Enterprise Value7.16M USD
Revenue (TTM)718.17K USD
Gross Profit400.11K USD
Net Income (TTM)-46.90M USD
Revenue/Share0.4420 USD
Last Price9.770 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees115
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS1897631057
Valuation
P/E (Trailing)—
P/E (Forward)-0.31
PEG—
EV/EBITDA-0.23
EV/Revenue9.98
P/S18.61
P/B0.83
EPS (TTM)-32.26
EPS (Forward)-12.00
52W Range
1.26019% of range46.50
52W High46.50 USD
52W Low1.260 USD
Profitability
Gross Margin64.28%
Oper. Margin-6309.12%
EBITDA Margin0.00%
Profit Margin-7533.62%
ROE-227.33%
ROA-189.54%
Growth
Revenue Growth190.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.14M USD
CapEx (TTM)700.05K USD
FCF Margin—
FCF Yield—
Net Debt-6.20M USD
Net Debt/EBITDA0.20
Balance Sheet
Debt/Equity0.06
Current Ratio2.28
Quick Ratio1.94
Book Value/Sh4.453 USD
Cash/Share2.285 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.60M
Float3.50M
Insiders3.34%
Institutions1.41%
Short Interest
Short Ratio0.7d
Short % Float2.72%
Short % Out.2.63%
Shares Short94.77K
Short (prev mo.)168.62K
Technical
SMA 501.847 (+429.1%)
SMA 2006.630 (+47.4%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)10.01M
Avg Vol (10d)23.96M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—